LevGertsikMD

PubMed

• 5 citations
  Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms.
  Daniel Umbricht, Markus Abt, Paul Tamburri, Christopher Chatham, Štefan Holiga, Michael J Frank, Anne G E Collins, David P Walling, Rick Mofsen, Daniel Gruener, Lev Ge...> ;Biological Psychiatry Global Open Science. 2021 Jun 1
• 11 citations
  Phase 1 randomized study on the safety, tolerability, and pharmacodynamic cognitive and electrophysiological effects of a dopamine D-1 receptor positive allosteric mod...
  Amit Desai, Lauren Benner, Ruishan Wu, Lev Gertsik, Paul Maruff, Gregory A. Light, Tolga Uz, Gerard J. Marek, Tong Zhu> ;Neuropsychopharmacology. 2021 May 1
• 1 citations
  Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies
  Amit Desai, Lauren Benner, Ruishan Wu, Lev Gertsik, Tolga Uz, Gerard J. Marek, Tong Zhu> ;Clinical Pharmacokinetics. 2021 Jan 1
• 9 citations
  A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia.
  Nicholas DeMartinis, Rene N. Lopez, Eve H. Pickering, Christopher J. Schmidt, Lev Gertsik, David P. Walling, Adam Ogden> ;Journal of Clinical Psychopharmacology. 2019 Jul 1
• 9 citations
  A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposu...
  Paul Goldsmith, John Affinito, Maggie McCue, Max Tsai, Stefan Roepcke, Jinhui Xie, Lev Gertsik, Thomas A. Macek> ;Drugs in R&D. 2017 Dec 1
• 61 citations
  AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
  Robert E. Litman, Mark A. Smith, James J. Doherty, Alan J. Cross, Shane Raines, Lev Gertsik, Stephen R. Zukin> ;Schizophrenia Research. 2014 Apr 1
• A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.
  Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freem...> ;Mol. Psychiatry. 2016-10-01
• 4 citations
  A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.
  M Fava, K Johe, L Ereshefsky, L G Gertsik, B A English, J A Bilello, L M Thurmond, J Johnstone, B C Dickerson, N Makris, B B Hoeppner, M Flynn, D Mischoulon, G Kinrys,...> ;Molecular Psychiatry. 2016 Oct 1
• 12 citations
  Safety and pharmacokinetics of lisdexamfetamine dimesylate in adults with clinically stable schizophrenia: a randomized, double-blind, placebo-controlled trial of asce...
  Patrick Martin, Bryan Dirks, Lev Gertsik, David P. Walling, Annette Stevenson, Mary Corcoran, Aparna Raychaudhuri, James Ermer> ;Journal of Clinical Psychopharmacology. 2014 Dec 1
• 9 citations
  Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia
  Brett A. English, Kelan L. Thomas, Jack Johnstone, Adam Bazih, Lev Gertsik, Larry Ereshefsky> ;Biomarkers in Medicine. 2014 Jan 1
• 10 citations
  Response to citalopram is not associated with SLC6A4 genotype in African-Americans and Caucasians with major depression.
  Russell E. Poland, Ira M. Lesser, Yu-Jui Yvonne Wan, Lev Gertsik, Jie Yao, Leslie J. Raffel, Keh Ming Lin, Hector F. Myers> ;Life Sciences. 2013 May 30
• 9 citations
  Open-Label, Randomized, Parallel-Group Controlled Clinical Trial of Massage for Treatment of Depression in HIV-Infected Subjects
  Russell E. Poland, Lev Gertsik, Joya T. Favreau, Shawnee I. Smith, James M. Mirocha, Uma Rao, Eric S. Daar> ;Journal of Alternative and Complementary Medicine. 2013 Apr 11
• 112 citations
  Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.
  Lev Gertsik, Russell E. Poland, Catherine Bresee, Mark Hyman Rapaport> ;Journal of Clinical Psychopharmacology. 2012 Feb 1
• 11 citations
  Effect of bupropion on nocturnal urinary free cortisol and its association with antidepressant response.
  Uma Rao, Geoffrey E. Ott, Keh-Ming Lin, Lev Gertsik, Russell E. Poland> ;Journal of Psychiatric Research. 2005 Mar 1
• 26 citations
  Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response
  Geoffrey E. Ott, Uma Rao, Keh-Ming Lin, Lev Gertsik, Russell E. Poland> ;The International Journal of Neuropsychopharmacology. 2004 Sep 1
• [Use of psychotropic drugs in general somatic practice].
  Smulevich, A. B., Gindikin, V. I. a., Avedisova, A. S., Vorontsova, E. A., Gertsik, L. G.> ;Zh Nevropatol Psikhiatr Im S S Korsakova. 1985 Jan 01
• [Premorbid characteristics and nature of the mental disorders in patients with neurocirculatory dystonia and heart rhythm disorders (clinico-psychological research)].
  Gertsik, L. G., Il'icheva, V. I., Kukes, V. G., Syrkina, E. A.> ;Zh Nevropatol Psikhiatr Im S S Korsakova. 1988
• [Mental disorders in functional disorders of cardiac activity and results of psychotropic and anti-arrhythmia therapy].
  Smulevich, A. B., Gindikin, V. I. a., Syrkina, E. A., Gertsik, L. G.> ;Klin Med (Mosk). 1989 Jan
• [Clinical and pharmacokinetic aspects of the problem of benzodiazepine derivatives (review of foreign literature)].
  Go'rkov, V. A., Tarasova, T. P., Gertsik, L. G.> ;Zh Nevropatol Psikhiatr Im S S Korsakova. 1989
• Join now to see all